Includes asymptomatic testing at community-based facilities to prevent widespread transmissions
Regular testing for COVID-19, flu, RSV crucial for staying safe as anti-virus restrictions are eased
PCR tests will be priced affordably, made possible through
"Full support for countries that join
There have been reports of an uptick in influenza and everyday colds which had been absent during the two-year pandemic, as countries worldwide ease social distancing restrictions and lift mask mandates. Experts have also warned that potentially dangerous mutations could go unnoticed due to scaled down PCR testing with governments no longer providing them for free. Individuals are now required to monitor their health at their own expense to stay safe.
- Preemptive asymptomatic testing. PCR tests can identify infected people with mild or even no symptoms. A study by the
U.S. CDC found that asymptomatic or presymptomatic individuals are responsible for around 60% of all COVID-19 transmission. Regular asymptomatic testing, even without doctor's prescription, is expected to help curb widespread infections at community facilities, such as schools, churches, or nursing homes and ensure safe return to normal life. - Syndromic respiratory testing. Syndromic testing is crucial for determining which virus is responsible for a person's symptoms and what treatment makes sense.
Seegene will provide Allplex™ SARS-CoV-2 FluA/FluB/RSV Assay, which can simultaneously detect SARS-CoV-2 (via the N, RdRP and S gene), influenza A and B, and RSV (A/B). The WHO recommends the screening of at least two target genes for SARS-CoV-2.Seegene's assay identifies three to maintain detection accuracy if new COVID-19 variants emerge. The six-target assay also includes two internal controls for added accuracy. - Increased PCR test accessibility and affordability. PCR testing has generally been acknowledged as very expensive.
Seegene will work with hospitals and labs so that a test can cost aroundUS$12 to boost accessibility and encourage routine testing. High multiplex technologies that build upon the company's 20+ years of expertise in molecular diagnostics have enabledSeegene to lower the barrier to access.
"The '
View original content to download multimedia:https://www.prnewswire.com/news-releases/seegene-unveils-12-pcr-testing-initiative-to-help-end-covid-19-pandemic-301554784.html
SOURCE
© Canada Newswire, source